Kuros Biosciences Ltd. | Ownership
Companies that own Kuros Biosciences Ltd.
Banque Pictet & Cie SA
692,255
8.41%
0
0.09%
12/31/2017
Schroder Investment Management North America, Inc.
116,450
1.41%
0
0.01%
12/31/2017
IFS Independent Financial Services AG
47,415
0.57%
43,751
1.01%
12/31/2017
Union Bancaire Privée, UBP SA
40,072
0.49%
10,916
0.02%
03/31/2018
Yorkville Advisors LLC
37,293
0.45%
37,293
3.98%
04/24/2018
Credit Suisse Asset Management (Schweiz) AG
29,338
0.36%
865
0%
05/31/2018
UBS AG (Investment Management)
23,437
0.28%
2,187
0%
12/29/2017
Herculis Partners SA
22,000
0.27%
22,000
1.05%
12/31/2017
Zürcher Kantonalbank (Investment Management)
20,450
0.25%
73
0%
07/31/2018
Aquila AG
10,133
0.12%
0
0.07%
07/31/2018
| Address |
Wagistrasse 25
Schlieren Zurich 8952
Switzerland
|
|
Employees
|
- |
| Website |
http://www.kurosbiosciences.com |
| Updated |
07/08/2019 |
| Kuros Biosciences Ltd. engages in the development of products for tissue repair and regeneration. Its products include sealants for tissue restore and orthobiologics for bone healing. The company was founded by Didier Cowling and Jason Schense in 2000 and is headquartered in Schlieren, Switzerland. |
